Chimeric Peptides from <i>Californiconus californicus</i> and <i>Heterodontus francisci</i> with Antigen-Binding Capacity: A Conotoxin Scaffold to Create Non-Natural Antibodies (NoNaBodies)
Research into various proteins capable of blocking metabolic pathways has improved the detection and treatment of multiple pathologies associated with the malfunction and overexpression of different metabolites. However, antigen-binding proteins have limitations. To overcome the disadvantages of the...
Main Authors: | Salvador Dueñas, Teresa Escalante, Jahaziel Gasperin-Bulbarela, Johanna Bernáldez-Sarabia, Karla Cervantes-Luévano, Samanta Jiménez, Noemí Sánchez-Campos, Olivia Cabanillas-Bernal, Blanca J. Valdovinos-Navarro, Angélica Álvarez-Lee, Marco A. De León-Nava, Alexei F. Licea-Navarro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/15/4/269 |
Similar Items
-
The Diversified O-Superfamily in <i>Californiconus californicus</i> Presents a Conotoxin with Antimycobacterial Activity
by: Johanna Bernáldez-Sarabia, et al.
Published: (2019-02-01) -
Systemic antihyperalgesic effect of a novel conotoxin from Californiconus californicus in an inflammatory pain model
by: Joaquín López-Carrillo, et al.
Published: (2025-01-01) -
Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from <i>Californiconus californicus</i>, for Treating Type 2 Diabetes
by: Pavel H. Lugo-Fabres, et al.
Published: (2021-08-01) -
In Vitro Effect of the Synthetic cal14.1a Conotoxin, Derived from Conus californicus, on the Human Parasite Toxoplasma gondii
by: Marco A. De León-Nava, et al.
Published: (2016-04-01) -
Conotoxin Patenting Trends in Academia and Industry
by: Noemi Sanchez-Campos, et al.
Published: (2022-08-01)